The Impact of COVID-19 Within Stage Migration and Upstage in Multiple Cancer Lineages
This retrospective study of over 16,000 patients reveals that the COVID-19 pandemic had a heterogeneous impact on cancer staging trends across different lineages, causing significant upstaging in lung, prostate, and colorectal cancers while paradoxically showing downstaging in breast cancer, with no significant changes observed for pancreatic and gastric cancers.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine the global healthcare system as a massive, well-oiled machine designed to catch diseases early, like a security team spotting a small leak before it floods the building. The COVID-19 pandemic was like a sudden, massive storm that forced the security team to stop patrolling the halls to fight the floodwaters directly.
This research paper asks a simple but critical question: When the storm passed and the security team tried to get back to work, did they find the leaks had grown bigger because they were ignored for so long?
The researchers, a team from Lakeland Regional Medical Center and Westchester Medical Center, looked at the medical records of over 16,000 cancer patients. They divided time into three distinct "seasons":
- Pre-COVID (PreC): The calm before the storm (2013–2020).
- During COVID (DC): The height of the storm (2020–2021).
- Post-COVID (PosC): The aftermath and recovery (2021–2024).
They examined six different types of "cancer leaks" (Breast, Colorectal, Lung, Prostate, Pancreas, and Gastric) to see if the size of the cancer at the time of diagnosis changed between these seasons.
Here is what they found, broken down by cancer type using simple analogies:
1. Breast Cancer: The "Early Warning System" Worked
- The Finding: Surprisingly, breast cancer was found at a smaller stage during and after the pandemic compared to before.
- The Analogy: Think of breast cancer screening like a very popular, well-marked fire alarm. Even when the pandemic hit, people were reminded to check their alarms. The study suggests that because breast cancer screening is so well-known and promoted, people didn't wait too long to get checked. Once the initial panic of the pandemic faded, the screening numbers bounced back quickly, catching the "leaks" while they were still tiny (Stage T1a) rather than letting them grow to a medium size (Stage T1b) as seen in the pre-pandemic era.
2. Colorectal, Lung, and Prostate Cancers: The "Hidden Leaks" Got Bigger
- The Finding: For these three cancers, the "leaks" were significantly larger when diagnosed during and after the pandemic compared to before.
- The Analogy: Imagine these cancers are like slow-dripping faucets hidden behind a wall.
- Colorectal (Colon): Before the storm, people regularly scheduled plumbing inspections (colonoscopies). During the storm, these inspections were canceled. The study found that many people didn't get checked until they had a major emergency (like a pipe bursting), meaning the cancer had grown from a small drip (Stage T2a) to a larger leak (Stage T2b) by the time doctors finally saw it.
- Lung and Prostate: These rely heavily on imaging scans (like CTs and MRIs) to find the problem early. During the pandemic, hospitals were so busy fighting the virus that these scans were delayed or canceled. The study found that by the time patients finally got their scans, the tumors had grown larger (upstaged) compared to the pre-pandemic era.
3. Pancreatic and Gastric (Stomach) Cancers: The "Silent Neighbors"
- The Finding: The study did not find a significant change in the size of these cancers across the three time periods.
- The Analogy: These cancers are notoriously difficult to catch early regardless of the situation. The study suggests that the pandemic didn't make a noticeable difference in their staging trends, possibly because they are often found at similar stages due to their nature, or the data wasn't large enough to see a clear pattern.
The Big Picture: The "COVID Effect"
The authors conclude that there is indeed a "COVID Effect," but it's not the same for every disease.
- For cancers with strong, well-known screening habits (like breast cancer), the system recovered quickly, and patients were still caught early.
- For cancers that rely on routine, non-emergency visits and complex imaging (like colon, lung, and prostate), the "storm" caused a delay. This delay allowed the diseases to grow larger before they were finally diagnosed.
In short: The pandemic acted like a pause button on healthcare. For some, the pause was short enough that the problem didn't get worse. For others, the pause was long enough that the problem grew significantly larger by the time the "play" button was pressed again. The study highlights that while we are back to "normal," the scars of that delay are visible in the size of the cancers being diagnosed today.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.